Generate a tailored SOP for Dr. Sarah Lisanby. Improve your application with a focused, well-structured draft.
Sarah Hollingsworth Lisanby, MD, is a distinguished translational researcher known for her innovative work in neuromodulation technologies aimed at studying and treating psychiatric disorders. She served as the Director of the Division of Translational Research at the National Institute of Mental Health (NIMH), where she was responsible for advancing research discoveries in the prevention, treatment, and potential cures for mental illness across the lifespan. Lisanby founded and directed the Noninvasive Neuromodulation Unit at the NIMH Intramural Research Program, fostering a multidisciplinary clinical research program that specializes in the innovation of new brain stimulation tools and measuring neuroplasticity to improve mental health outcomes. She has held prominent leadership roles, including Chair of the Department of Psychiatry & Behavioral Sciences at Duke University and has received several international awards for her contributions to the field. Lisanby is actively involved in leading federally funded projects aimed at the development of novel neuromodulation therapies, with a particular focus on the rational design of magnetic and electrical seizure therapies. Her research includes pioneering work on magnetic seizure therapy as a new treatment for depression, and she has overseen numerous clinical studies involving various brain stimulation techniques. In addition to her research activities, she has contributed to professional associations and advisory panels, advocating for advancements in psychiatric treatment practices.
Department of Biomedical Engineering (MS program)